NADPH oxidases: An overview from structure to innate immunity-associated pathologies

Cellular and Molecular Immunology

Volumn 12, Issue 1, 2015, Pages 5-23

  Panday, Arvind ^a,d   Sahoo, Malaya K ^b   Osorio, Diana ^a   Batra, Sanjay ^a,c  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SOUTHERN UNIVERSITY   (United States)

^d LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

alcohol; COPD; NLRs; NOX; TLRs

Indexed keywords

3 BENZYL 7 (2-BENZOXAZOYL)THIO 1,2,3 TRIAZOLO[4,5,D]PYRIMIDINE; APOCYNIN; CIGARETTE SMOKE; ENZYME INHIBITOR; GOMICIN C; HONOKIOL; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; OXIDOREDUCTASE INHIBITOR; PLUMBAGIN; RAC PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE INHIBITOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; OXIDOREDUCTASE;

ALCOHOL CONSUMPTION; BACTERIAL INFECTION; BINDING AFFINITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME STRUCTURE; HOST RESISTANCE; HUMAN; IMMUNOPATHOLOGY; INNATE IMMUNITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TISSUE REPAIR; VASCULAR DISEASE; VIRUS PATHOGENESIS; ANGIOGENESIS; ANIMAL; CONFORMATION; DNA DAMAGE; IMMUNOLOGY; INFECTION; METABOLISM; STRUCTURE ACTIVITY RELATION; WOUND HEALING;

BACTERIA (MICROORGANISMS);

ANIMALS; DNA DAMAGE; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNITY, INNATE; INFECTION; MOLECULAR CONFORMATION; NADH, NADPH OXIDOREDUCTASES; NEOVASCULARIZATION, PHYSIOLOGIC; REACTIVE OXYGEN SPECIES; STRUCTURE-ACTIVITY RELATIONSHIP; WOUND HEALING;

EID: 84920520188     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2014.89     Document Type: Review

References (290)

1. Smeyne M, Smeyne RJ. Glutathione metabolism and Parkinson's disease. Free Radic Biol Med 2013; 62: 13-25
2. Aliev G, Priyadarshini M, Reddy VP, Grieg NH, Kaminsky Y, Cacabelos R et al. Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease. Curr Med Chem 2014; 21: 2208-2217
3. Robert AM, Robert L. Xanthine oxido-reductase, free radicals and cardiovascular disease. A critical review. Pathol Oncol Res 2014; 20: 1-10
4. Deken XD, Corvilain B, Dumont JE, Miot F. Roles of DUOX-mediated hydrogen peroxide in metabolism, host defense, and signaling. Antioxid Redox Signal 2014; 20: 2776-2793
5. Xin G, Du J, Wang YT, Liang TT. Effect of oxidative stress on heme oxygenase-1 expression in patients with gestational diabetes mellitus. Exp Ther Med 2014; 7: 478-482
6. Franchini AM, Hunt D, Melendez JA, Drake JR. FcgammaR-driven release of IL-6 by macrophages requires NOX2-dependent production of reactive oxygen species. J Biol Chem 2013; 288: 25098-25108
7. Cross AR, Segal AW. The NADPH oxidase of professional phagocytes-prototype of the NOX electron transport chain systems. Biochim Biophys Acta 2004; 1657: 1-22
8. Touyz RM, Briones AM, Sedeek M, Burger D, Montezano AC. NOX isoforms and reactive oxygen species in vascular health. Mol Interv 2011; 11: 27-35
9. Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine 2000; 79: 155-169
10. Quie PG, White JG, Holmes B, Good RA. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest 1967; 46: 668-679
11. Holmes B, Quie PG, Windhorst DB, Good RA. Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet 1966; 1: 1225-1228
12. Bylund J, Goldblatt D, Speert DP. Chronic granulomatous disease: from genetic defect to clinical presentation. Adv Exp Med Biol 2005; 568: 67-87
13. Quinn MT, Ammons MC, Deleo FR. The expanding role of NADPH oxidases in health and disease: no longer just agents of death and destruction. Clin Sci 2006; 111: 1-20
14. Brandes RP, Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 2005; 65: 16-27
15. Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 2004; 122: 339-352
16. Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 2006; 147(Suppl 1): S193-S201
17. Cifuentes ME, Pagano PJ. Targeting reactive oxygen species in hypertension. Curr Opin Nephrol Hypertens 2006; 15: 179-186
18. Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: A critical link to hypertension?. Am J Physiol Regul Integr Comp Physiol 2005; 289: R913-R935
19. Wilcox CS. Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol Scand 2003; 179: 217-223
20. Zou AP, Cowley AW Jr. Reactive oxygen species and molecular regulation of renal oxygenation. Acta Physiol Scand 2003; 179: 233-241
21. Juncos R, Hong NJ, Garvin JL. Differential effects of superoxide on luminal and basolateral Na1/H1 exchange in the thick ascending limb. Am J Physiol Regul Integr Comp Physiol 2006; 290: R79-R83
22. Hoidal JR, Brar SS, Sturrock AB, Sanders KA, Dinger B, Fidone S et al. The role of endogenous NADPH oxidases in airway and pulmonary vascular smooth muscle function. Antioxid Redox Signal 2003; 5: 751-758
23. Brar SS, Kennedy TP, Sturrock AB, Huecksteadt TP, Quinn MT, Murphy TM et al. NADPH oxidase promotes NF-kappaB activation and proliferation in human airway smooth muscle.AmJ Physiol Lung Cell Mol Physiol 2002; 282: L782-L795
24. Piao YJ, Seo YH, Hong F, Kim JH, Kim YJ, Kang MH et al. Nox 2 stimulates muscle differentiation via NF-kappaB/iNOS pathway. Free Radic Biol Med 2005; 38: 989-1001
25. Kojim S, Ikeda M, Shibukawa A, Kamikawa Y. Modification of 5-hydroxytryptophan-evoked 5-hydroxytryptamine formation of guinea pig colonic mucosa by reactive oxygen species. Jpn J Pharmacol 2002; 88: 114-118
26. Wang G, Anrather J, Huang J, Speth RC, Pickel VM, Iadecola C. NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius. J Neurosci 2004; 24: 5516-5524
27. Erdos B, Broxson CS, King MA, Scarpace PJ, Tumer N. Acute pressor effect of central angiotensin II is mediated by NAD(P)H-oxidasedependent production of superoxide in the hypothalamic cardiovascular regulatory nuclei. J Hypertens 2006; 24: 109-116
28. Mander PK, Jekabsone A, Brown GC. Microglia proliferation is regulated by hydrogen peroxide from NADPH oxidase. J Immunol 2006; 176:1046-1052
29. Sbarra AJ, Karnovsky ML. The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem 1959; 234: 1355-1362
30. Iyer GY, Islam MF, Quastel JH. Biochemical aspects of phagocytosis. Nature 1961; 192: 535-541
31. Rossi F, Zatti M. Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells. Experientia 1964; 20: 21-23
32. Babior BM, Kipnes RS, Curnutte JT. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 1973; 52: 741-744
33. Segal AW, Jones OT. Novel cytochrome b system in phagocytic vacuoles of human granulocytes. Nature 1978; 276: 515-517
34. Segal AW, Jones OT, Webster D, Allison AC. Absence of a newly described cytochrome b from neutrophils of patients with chronic granulomatous disease. Lancet 1978; 2: 446-449
35. Teahan C, Rowe P, Parker P, Totty N, Segal AW. The X-linked chronic granulomatous disease gene codes for the beta-chain of cytochrome b-245. Nature 1987; 327: 720-721
36. Dinauer MC, Orkin SH, Brown R, Jesaitis AJ, Parkos CA. The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature 1987; 327: 717-720
37. Nunoi H, Rotrosen D, Gallin JI, Malech HL. Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors. Science 1988; 242: 1298-1301
38. Volpp BD, Nauseef WM, Clark RA. Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. Science 1988; 242: 1295-1297
39. Baehner RL, Gilman N, Karnovsky ML. Respiration and glucose oxidation in human and guinea pig leukocytes: comparative studies. J Clin Invest 1970; 49: 692-700
40. Babior BM. NADPH oxidase: An update. Blood 1999; 93: 1464-1476
41. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT et al. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 2002; 90: 1205-1213
42. Diebold BA, Bokoch GM. Molecular basis for Rac2 regulation of phagocyte NADPH oxidase. Nat Immunol 2001; 2: 211-215
43. Grizot S, Faure J, Fieschi F, Vignais PV, Dagher MC, Pebay-Peyroula E. Crystal structure of the Rac1-RhoGDI complex involved in nadph oxidase activation. Biochemistry 2001; 40: 10007-10013
44. Takahashi M, Dillon TJ, Liu C, Kariya Y, Wang Z, Stork PJ. Protein kinase A-dependent phosphorylation of Rap1 regulates its membrane localization and cell migration. J Biol Chem 2013; 288: 27712-27723
45. Heyworth PG, Knaus UG, Settleman J, Curnutte JT, Bokoch GM. Regulation of NADPH oxidase activity by Rac GTPase activating protein(s). Mol Biol Cell 1993; 4: 1217-1223
46. Dusi S, Donini M, Rossi F. Mechanisms of NADPH oxidase activation: translocation of p40phox, Rac1 and Rac2 from the cytosol to the membranes in human neutrophils lacking p47phox or p67phox. Biochem J 1996; 314(Pt 2): 409-412
47. Flannagan RS, Cosio G, Grinstein S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol 2009; 7: 355-366
48. Abate C, Patel L, Rauscher FJ 3rd, Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 1990; 249: 1157-1161
49. Borregaard N, Heiple JM, Simons ER, Clark RA. Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol 1983; 97: 52-61
50. Huang J, Hitt ND, Kleinberg ME. Stoichiometry of p22-phox and gp91-phox in phagocyte cytochrome b558. Biochemistry 1995; 34: 16753-16757
51. Groemping Y, Rittinger K. Activation and assembly of the NADPH oxidase: A structural perspective. Biochem J 2005; 386(Pt 3): 401-416
52. Nauseef WM. Assembly of the phagocyte NADPH oxidase. Histochem Cell Biol 2004; 122: 277-291
53. Sumimoto H, Miyano K, Takeya R. Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem Biophys Res Commun 2005; 338: 677-686
54. Koga H, Terasawa H, Nunoi H, Takeshige K, Inagaki F, Sumimoto H. Tetratricopeptide repeat (TPR) motifs of p67(phox) participate in interaction with the small GTPase Rac and activation of the phagocyte NADPH oxidase. J Biol Chem 1999; 274: 25051-25060
55. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999; 401: 79-82
56. Banfi B, Maturana A, Jaconi S, Arnaudeau S, Laforge T, SinhaB et al. A mammalian H1 channel generated through alternative splicing of the NADPH oxidase homolog NOH-1. Science 2000; 287: 138-142
57. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2004; 24: 677-683
58. Balamayooran G, Batra S, Theivanthiran B, Cai S, Pacher P, Jeyaseelan S. Intrapulmonary G-CSF rescues neutrophil recruitment to the lung and neutrophil release to blood in Gram-negative bacterial infection in MCP-12/2 mice. J Immunol 2012; 189: 5849-5859
59. Fukata M, Hernandez Y, Conduah D, Cohen J, Chen A, BreglioK et al. Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-Associated tumors. Inflamm Bowel Dis 2009; 15: 997-1006
60. Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, ShimizuMet al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 2000; 58: 1492-1499
61. Szanto I, Rubbia-Brandt L, Kiss P, Steger K, Banfi B, Kovari E et al. Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol 2005; 207: 164-176
62. Banfi B, Clark RA, Steger K, Krause KH. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem 2003; 278: 3510-3513
63. Cheng G, Lambeth JD. NOXO1, regulation of lipid binding, localization, and activation of Nox1 by the Phox homology (PX) domain. J Biol Chem 2004; 279: 4737-4742
64. Geiszt M, Lekstrom K, Witta J, Leto TL. Proteins homologous to p47phox and p67phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells. J Biol Chem 2003; 278: 20006-20012
65. Takeya R, Ueno N, Kami K, Taura M, Kohjima M, Izaki T et al. Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases. J Biol Chem 2003; 278: 25234-25246
66. Ueyama T, Geiszt M, Leto TL. Involvement of Rac1 in activation of multicomponent Nox1- and Nox3-based NADPH oxidases. Mol Cell Biol 2006; 26: 2160-2174
67. Kikuchi H, Hikage M, Miyashita H, Fukumoto M. NADPH oxidase subunit, gp91(phox) homologue, preferentially expressed in human colon epithelial cells. Gene 2000; 254: 237-243
68. Miyano K, Ueno N, Takeya R, Sumimoto H. Direct involvement of the small GTPase Rac in activation of the superoxide-producing NADPH oxidase Nox1. J Biol Chem 2006; 281: 21857-21868
69. Park HS, Lee SH, Park D, Lee JS, Ryu SH, Lee WJ et al. Sequential activation of phosphatidylinositol 3-kinase, beta Pix, Rac1, and Nox1 in growth factor-induced production of H2O2. Mol Cell Biol 2004; 24: 4384-4394
70. Ueno N, Takeya R, Miyano K, Kikuchi H, Sumimoto H. The NADPH oxidase Nox3 constitutively produces superoxide in a p22phoxdependent manner: its regulation by oxidase organizers and activators. J Biol Chem 2005; 280: 23328-23339
71. Kawahara T, Ritsick D, Cheng G, Lambeth JD. Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation. J Biol Chem 2005; 280: 31859-31869
72. Cheng G, Ritsick D, Lambeth JD. Nox3 regulation by NOXO1, p47phox, and p67phox. J Biol Chem 2004; 279: 34250-34255
73. Kiss PJ, Knisz J, Zhang Y, Baltrusaitis J, Sigmund CD, Thalmann R et al. Inactivation of NADPH oxidase organizer 1 results in severe imbalance. Curr Biol 2006; 16: 208-213
74. Geiszt M, Kopp JB, Varnai P, Leto TL. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 2000; 97: 8010-8014
75. Ambasta RK, Kumar P, Griendling KK, Schmidt HH, Busse R, Brandes RP. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 2004; 279: 45935-45941
76. Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, Knaus UG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signall 2006; 18: 69-82
77. Gorin Y, Ricono JM, Kim NH, Bhandari B, Choudhury GG, Abboud HE. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am J Physiol Renal Physiol 2003; 285: F219-F229
78. Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P et al. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res 2009; 105: 249-259
79. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007; 87: 245-313
80. Banfi B, Molnar G, Maturana A, Steger K, Hegedus B, Demaurex N et al. A Ca21-Activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem 2001; 276: 37594-37601
81. Cheng G, Cao Z, Xu X, van Meir EG, Lambeth JD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 2001; 269: 131-140
82. Banfi B, Tirone F, Durussel I, Knisz J, Moskwa P, Molnar GZ et al. Mechanism of Ca21 activation of the NADPH oxidase 5 (NOX5). J Biol Chem 2004; 279: 18583-18591
83. Fu X, Beer DG, Behar J, Wands J, Lambeth D, Cao W. cAMP-response element-binding protein mediates acid-induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells. J Biol Chem 2006; 281: 20368-20382
84. Colas C, Ortiz de Montellano PR. Autocatalytic radical reactions in physiological prosthetic heme modification. Chem Rev 2003; 103: 2305-2332
85. Daiyasu H, Toh H. Molecular evolution of the myeloperoxidase family. J Mol Evol 2000; 51: 433-445
86. Nauseef WM. Contributions of myeloperoxidase to proinflammatory events: more than an antimicrobial system. Int J Hematol 2001; 74: 125-133
87. Dupuy C, Virion A, Ohayon R, Kaniewski J, Deme D, Pommier J. Mechanism of hydrogen peroxide formation catalyzed by NADPH oxidase in thyroid plasma membrane. J Biol Chem 1991; 266: 3739-3743
88. De Deken X, Wang D, Dumont JE, Miot F. Characterization of ThOX proteins as components of the thyroid H2O2-generating system. Exp Cell Res 2002; 273: 187-196
89. Morand S, Chaaraoui M, Kaniewski J, Deme D, Ohayon R, Noel-Hudson MS et al. Effect of iodide on nicotinamide adenine dinucleotide phosphate oxidase activity and Duox2 protein expression in isolated porcine thyroid follicles. Endocrinology 2003; 144: 1241-1248
90. de Deken X, Wang D, Many MC, Costagliola S, Libert F, Vassart G et al. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 2000; 275: 23227-23233
91. Dupuy C, Ohayon R, Valent A, Noel-Hudson MS, Deme D, Virion A. Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cdnas. J Biol Chem 1999; 274: 37265-37269
92. Grasberger H, Refetoff S. Identification of the maturation factor for dual oxidase. Evolution of an eukaryotic operon equivalent. J Biol Chem 2006; 281: 18269-18272
93. Ameziane-El-Hassani R, Morand S, Boucher JL, Frapart YM, Apostolou D, Agnandji D et al. Dual oxidase-2 has an intrinsic Ca21-dependent H2O2-generating activity. J Biol Chem 2005; 280: 30046-30054
94. Wang D, de Deken X, MilenkovicM, Song Y, Pirson I, Dumont JE et al. Identification of a novel partner of duox: EFP1, a thioredoxin-related protein. J Biol Chem 2005; 280: 3096-3103
95. Heyworth PG, Curnutte JT, Nauseef WM, Volpp BD, Pearson DW, Rosen H et al. Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558. J Clin Invest 1991; 87: 352-356
96. Freeman JL, Lambeth JD. NADPH oxidase activity is independent of p47phox in vitro. J Biol Chem 1996; 271: 22578-22582
97. Nisimoto Y, Freeman JL, Motalebi SA, Hirshberg M, Lambeth JD. Rac binding to p67(phox). Structural basis for interactions of the Rac1 effector region and insert region with components of the respiratory burst oxidase. J Biol Chem 1997; 272: 18834-18841
98. Cross AR, Curnutte JT. The cytosolic activating factors p47phox and p67phox have distinct roles in the regulation of electron flow in NADPH oxidase. J Biol Chem 1995; 270: 6543-6548
99. Doussiere J, Brandolin G, Derrien V, Vignais PV. Critical assessment of the presence of an NADPH binding site on neutrophil cytochrome b558 by photoaffinity and immunochemical labeling. Biochemistry 1993; 32: 8880-8887
100. Ravel P, Lederer F. Affinity-labeling of an NADPH-binding site on the heavy subunit of flavocytochrome b558 in particulate NADPH oxidase from activated human neutrophils. Biochem Biophys Res Commun 1993; 196: 543-552
101. Smith RM, Connor JA, Chen LM, Babior BM. The cytosolic subunit p67phox contains an NADPH-binding site that participates in catalysis by the leukocyte NADPH oxidase. J Clin Invest 1996; 98: 977-983
102. Allen LA, DeLeo FR, Gallois A, Toyoshima S, Suzuki K, Nauseef WM. Transient association of the nicotinamide adenine dinucleotide phosphate oxidase subunits p47phox and p67phox with phagosomes in neutrophils from patients with X-linked chronic granulomatous disease. Blood 1999; 93: 3521-3530
103. Koshkin V, Pick E. Generation of superoxide by purified and relipidated cytochrome b559 in the absence of cytosolic activators. FEBS Lett 1993; 327: 57-62
104. Segal AW, Abo A. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem Sci 1993; 18: 43-47
105. Morel F, Doussiere J, Vignais PV. The superoxide-generating oxidase of phagocytic cells. Physiological, molecular and pathological aspects. Eur J Biochem 1991; 201: 523-546
106. Cross AR, Rae J, Curnutte JT. Cytochrome b-245 of the neutrophil superoxide-generating system contains two nonidentical hemes. Potentiometric studies of a mutant form of gp91phox. J Biol Chem 1995; 270: 17075-17077
107. Doussiere J, Gaillard J, Vignais PV. Electron transfer across the O2-generating flavocytochrome b of neutrophils. Evidence for a transition from a low-spin state to a high-spin state of the heme iron component. Biochemistry 1996; 35: 13400-13410
108. Yu L, Zhen L, Dinauer MC. Biosynthesis of the phagocyte NADPH oxidase cytochrome b558. Role of heme incorporation and heterodimer formation in maturation and stability of gp91phox and p22phox subunits. J Biol Chem 1997; 272: 27288-27294
109. Leusen JH, de Klein A, Hilarius PM, Ahlin A, Palmblad J, Smith CI et al. Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous disease. J Exp Med 1996; 184: 1243-1249
110. Parkos CA, Dinauer MC, Jesaitis AJ, Orkin SH, Curnutte JT. Absence of both the 91 kD and 22 kD subunits of human neutrophil cytochrome b in two genetic forms of chronic granulomatous disease. Blood 1989; 73: 1416-4120
111. Cross AR. p40(phox) Participates in the activation of NADPH oxidase by increasing the affinity of p47(phox) for flavocytochrome b(558). Biochem J 2000; 349(Pt 1): 113-117
112. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002; 420: 629-635
113. Gu Y, Jasti AC, Jansen M, Siefring JE. RhoH, a hematopoieticspecific Rho GTPase, regulates proliferation, survival, migration, and engraftment of hematopoietic progenitor cells. Blood 2005; 105: 1467-1475
114. Hordijk PL. Regulation of NADPH oxidases: the role of Rac proteins. Circ Res 2006; 98:453-462
115. Gu Y, Jia B, Yang FC, D'Souza M, Harris CE, Derrow CW et al. Biochemical and biological characterization of a human Rac2 GTPase mutant associated with phagocytic immunodeficiency. J Biol Chem 2001; 276: 15929-15938
116. Roberts AW, Kim C, Zhen L, Lowe JB, Kapur R, Petryniak B et al. Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense. Immunity 1999; 10: 183-196
117. Wu J, Cho MI, Kuramitsu HK. Expression, purification, and characterization of a novel G protein, SGP, from Streptococcus mutans. Infect Immun 1995; 63: 2516-2521
118. Freeman JL, Abo A, Lambeth JD. Rac "insert region" is a novel effector region that is implicated in the activation of NADPH oxidase, but not PAK65. J Biol Chem 1996; 271: 19794-19801
119. Dang PM, Cross AR, Quinn MT, Babior BM. Assembly of the neutrophil respiratory burst oxidase: A direct interaction between p67PHOX and cytochrome b558 II. Proc Natl Acad Sci USA 2002; 99: 4262-4265
120. Dang PM, Cross AR, Babior BM. Assembly of the neutrophil respiratory burst oxidase: A direct interaction between p67PHOX and cytochrome b558. Proc Natl Acad Sci USA 2001; 98: 3001-3005
121. Dang PM, Johnson JL, Babior BM. Binding of nicotinamide adenine dinucleotide phosphate to the tetratricopeptide repeat domains at the N-terminus of p67PHOX, a subunit of the leukocyte nicotinamide adenine dinucleotide phosphate oxidase. Biochemistry 2000; 39: 3069-3075
122. Williams DA, TaoW, Yang F, Kim C, Gu Y, Mansfield P et al. Dominant negativemutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood 2000; 96: 1646-1654
123. Segal AW. The NADPH oxidase and chronic granulomatous disease. Mol Med Today 1996; 2: 129-135
124. Ambruso DR, Knall C, Abell AN, Panepinto J, Kurkchubasche A, Thurman G et al. Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci USA 2000; 97: 4654-4659
125. Kamdar K, Nguyen V, DePaolo RW. Toll-like receptor signaling and regulation of intestinal immunity. Virulence 2013; 4: 207-212
126. O'Neill LA, Bowie AG. The family of five: Tir-domain-containing adaptors in toll-like receptor signalling. Nat Rev Immunol 2007; 7: 353-364
127. Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 2007; 13: 460-469
128. Nada M, Ohnishi H, Tochio H, Kato Z, Kimura T, Kubota K et al. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling. Mol Immunol 2012; 52: 108-116
129. Park BS, Lee JO. Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp Mol Med 2013; 45: e66
130. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801
131. Harton JA, Linhoff MW, Zhang J, Ting JP. Cutting edge: CATERPILLER: A large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains. J Immunol 2002; 169: 4088-4093
132. Ting JP, Williams KL. The CATERPILLER family: An ancient family of immune/apoptotic proteins. Clin Immunol 2005; 115: 33-37
133. Okugawa T, Kaneko T, Yoshimura A, SilvermanN, Hara Y. NOD1 and NOD2 mediate sensing of periodontal pathogens. J Dent Res 2010; 89: 186-191
134. Boyden ED, Dietrich WF. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 2006; 38: 240-244
135. Kanneganti TD, Body-Malapel M, Amer A, Park JH, Whitfield J, Franchi L et al. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem 2006; 281: 36560-36568
136. Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006; 24: 317-327
137. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Goutassociated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440: 237-241
138. Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 2007; 14: 10-22
139. Chen Q, Powell DW, Rane MJ, Singh S, Butt W, Klein JB et al. Akt phosphorylates p47phox and mediates respiratory burst activity in human neutrophils. J Immunol 2003; 170: 5302-5308
140. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675-680
141. Park HS, Jung HY, Park EY, Kim J, Lee WJ, Bae YS. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol 2004; 173: 3589-3593
142. Park HS, Chun JN, Jung HY, Choi C, Bae YS. Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells. Cardiovasc Res 2006; 72: 447-455
143. Lambeth JD. Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. Curr Opin Hematol 2002; 9: 11-17
144. Takeya R, Sumimoto H. Molecular mechanism for activation of superoxide-producing NADPH oxidases. Mol Cells 2003; 16: 271-277
145. Van Maele L, Carnoy C, Cayet D, Songhet P, Dumoutier L, Ferrero I et al. TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3negCD1271 immune cells in spleen and mucosa. J Immunol 2010; 185: 1177-1185
146. Kawahara T, Kuwano Y, Teshima-Kondo S, Takeya R, Sumimoto H, Kishi K et al. Role of nicotinamide adenine dinucleotide phosphate oxidase 1 in oxidative burst response to Toll-like receptor 5 signaling in large intestinal epithelial cells. J Immunol 2004; 172: 3051-3058
147. Andersen-Nissen E, Smith KD, Strobe KL, Barrett SL, Cookson BT, Logan SM et al. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci USA 2005; 102: 9247-9252
148. Smith KD, Andersen-Nissen E, Hayashi F, Strobe K, Bergman MA, Barrett SL et al. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol 2003; 4: 1247-1253
149. Joo JH, Ryu JH, Kim CH, Kim HJ, Suh MS, Kim JO et al. Dual oxidase 2 is essential for the toll-like receptor 5-mediated inflammatory response in airway mucosa. Antioxid Redox Signal 2012; 16: 57-70
150. Sangle GV, Zhao R, Mizuno TM, Shen GX. Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells. Endocrinology 2010; 151: 4455-4466
151. Bauernfeind F, Bartok E, Rieger A, Franchi L, Nunez G, Hornung V. Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J Immunol 2011; 187: 613-617
152. Hamilton RF Jr, Thakur SA, Holian A. Silica binding and toxicity in alveolar macrophages. Free Radic Biol Med 2008; 44: 1246-1258
153. Lipinski S, Till A, Sina C, Arlt A, Grasberger H, Schreiber S et al. DUOX2-derived reactive oxygen species are effectors of NOD2-mediated antibacterial responses. J Cell Sci 2009; 122(Pt 19): 3522-3530
154. Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L, Novembrino C et al. Oxidative stress and homocysteine in coronary artery disease. Clin Chem 2001; 47: 887-892
155. Ientile R, Curro M, Ferlazzo N, Condello S, Caccamo D, Pisani F. Homocysteine, vitamin determinants and neurological diseases. Front Biosci 2010; 2: 359-372
156. Gill PS, Wilcox CS. NADPH oxidases in the kidney. Antioxid Redox Signal 2006; 8: 1597-1607
157. Zhang C, Hu JJ, Xia M, Boini KM, Brimson CA, Laperle LA et al. Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene. Free Radic Biol Med 2010; 48: 1109-1117
158. Abais JM, Zhang C, Xia M, Liu Q, Gehr TW, Boini KM et al. NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia. Antioxid Redox Signal 2013; 18: 1537-1548
159. Gao HM, Zhou H, Hong JS. NADPH oxidases: novel therapeutic targets for neurodegenerative diseases. Trends Pharmacol Sci 2012; 33(6): 295-303
160. Furie MB, Randolph GJ. Chemokines and tissue injury. Am J Pathol 1995; 146: 1287-1301
161. Tan JH, Ludeman JP, Wedderburn J, Canals M, Hall P, Butler SJ et al. Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1). J Biol Chem 2013; 288: 10024-10034
162. Brandes RP, Viedt C, Nguyen K, Beer S, Kreuzer J, Busse R et al. Thrombin-induced MCP-1 expression involves activation of the p22phox-containing NADPH oxidase in human vascular smooth muscle cells. Thromb Haemost 2001; 85: 1104-1110
163. Chen Y, Zhang AH, Huang SM, Ding GX, Zhang WZ, Bao HY et al. NADPH oxidase-derived reactive oxygen species involved in angiotensin II-induced monocyte chemoattractant protein-1 expression in mesangial cells. Zhonghua Bing Li Xue Za Zhi 2009; 38: 456-461. Chinese
164. Cho SO, Lim JW, Kim H. Red ginseng extract inhibits the expression of MCP-1 and iNOS in Helicobacter pylori-infected gastric epithelial cells by suppressing the activation of NADPH oxidase and Jak2/tat3. J Ethnopharmacol 2013; 150: 761-764
165. Snelgrove R, Williams A, Thorpe C, Hussell T. Manipulation of immunity to and pathology of respiratory infections. Expert Rev Anti Infect Ther 2004; 2: 413-426
166. Snelgrove RJ, Edwards L, Rae AJ, Hussell T. An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur J Immunol 2006; 36: 1364-1373
167. Vlahos R, Stambas J, Selemidis S. Suppressing production of reactive oxygen species (ROS) for influenza A virus therapy. Trends Pharmacol Sci 2012; 33: 3-8
168. Suliman HB, Ryan LK, Bishop L, Folz RJ. Prevention of influenzainduced lung injury in mice overexpressing extracellular superoxide dismutase. Am J Physiol Lung Cell Mol Physiol 2001; 280: L69-L78
169. Akaike T. Role of free radicals in viral pathogenesis and mutation. Rev Med Virol 2001; 11: 87-101
170. Bureau C, Bernad J, Chaouche N, Orfila C, Beraud M, Gonindard C et al. Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J Biol Chem 2001; 276: 23077-23083
171. de Mochel NS, Seronello S, Wang SH, Ito C, Zheng JX, Liang TJ et al. Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology 2010; 52: 47-59
172. Boudreau HE, Emerson SU, Korzeniowska A, Jendrysik MA, Leto TL. Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: A new contributor to HCV-induced oxidative stress. J Virol 2009; 83: 12934-12946
173. Lambeth JD, Kawahara T, Diebold B. Regulation of Nox and Duox enzymatic activity and expression. Free Radic Biol Med 2007; 43: 319-331
174. Nelson DR, Gonzalez-Peralta RP, Qian K, Xu Y, Marousis CG, Davis GL et al. Transforming growth factor-beta 1 in chronic hepatitis C. J Viral Hepatitis 1997; 4: 29-35
175. Tamimi A, Serdarevic D, Hanania NA. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. Respir Med 2012; 106: 319-328
176. Gu F, Wacholder S, Kovalchik S, Panagiotou OA, Reyes-Guzman C, Freedman ND et al. Time to smoke first morning cigarette and lung cancer in a case-control study. J Natl Cancer Inst 2014; 106: dju118
177. Talbot S, Lin JC, Lahjouji K, Roy JP, Senecal J, Morin A et al. Cigarette smoke-induced kinin B1 receptor promotes NADPH oxidase activity in cultured human alveolar epithelial cells. Peptides 2011; 32: 1447-1456
178. Marceau F, Regoli D. Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov 2004; 3: 845-852
179. Martin JG, Suzuki M, Maghni K, Pantano R, Ramos-Barbon D, Ihaku D et al. The immunomodulatory actions of prostaglandin E2 on allergic airway responses in the rat. J Immunol 2002; 169: 3963-3969
180. Lin CC, Lee IT, Yang YL, Lee CW, Kou YR, Yang CM. Induction of COX-2/PGE(2)/IL-6 is crucial for cigarette smoke extract-induced airway inflammation: Role of TLR4-dependent NADPH oxidase activation. Free Radic Biol Med 2010; 48: 240-254
181. Noguera A, Busquets X, Sauleda J, Villaverde JM, MacNeeW, Agusti AG. Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158(5 Pt 1): 1664-1668
182. Noguera A, Batle S, Miralles C, Iglesias J, Busquets X, MacNee W et al. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 2001; 56: 432-437
183. Zhou MJ, Brown EJ. CR3(Mac-1, alphaMbeta 2, CD11b/CD18) and Fc gamma RIII cooperate in generation of a neutrophil respiratory burst: requirement for Fc gamma RIII and tyrosine phosphorylation. J Cell Biol 1994; 125: 1407-1416
184. Lowell CA, Fumagalli L, Berton G. Deficiency of Src family kinases p59/61 hck and p58c-fgr results in defective adhesion-dependent neutrophil functions. J Cell Biol 1996; 133: 895-910
185. Liles WC, Ledbetter JA, Waltersdorph AW, Klebanoff SJ. Crosslinking of CD18 primes human neutrophils for activation of the respiratory burst in response to specific stimuli: implications for adhesion-dependent physiological responses in neutrophils. J Leuk Biol 1995; 58: 690-697
186. MacNee W. Oxidants/antioxidants and chronic obstructive pulmonary disease: pathogenesis to therapy. Novartis Found Symp 2001; 234: 169-185; discussion 185-188
187. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-Alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153: 530-534
188. Cross CE, van der Vliet A, O'Neill CA, Louie S, Halliwell B. Oxidants, antioxidants, and respiratory tract lining fluids. Environ Health Perspect 1994; 102(Suppl 10): 185-191
189. Yeligar SM, Harris FL, Hart CM, Brown LA. Ethanol induces oxidative stress in alveolar macrophages via upregulation of NADPH oxidases. J Immunol 2012; 188: 3648-3657
190. Holguin F, Moss I, Brown LA, Guidot DM. Chronic ethanol ingestion impairs alveolar type II cell glutathione homeostasis and function and predisposes to endotoxin-mediated acute edematous lung injury in rats. J Clin Invest 1998; 101: 761-768
191. Yeh MY, Burnham EL, Moss M, Brown LA. Chronic alcoholism alters systemic and pulmonary glutathione redox status. Am J Respir Crit Care Med 2007; 176: 270-276
192. Szabo G. Consequences of alcohol consumption on host defence. Alcohol Alcohol 1999; 34: 830-841
193. Dushoff J, Plotkin JB, Viboud C, Earn DJ, Simonsen L. Mortality due to influenza in the United States-An annualized regression approach using multiple-cause mortality data. Am J Epidemiol 2006; 163: 181-187
194. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S et al. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 1996; 15: 5336-5348
195. Polikandriotis JA, Rupnow HL, Elms SC, Clempus RE, Campbell DJ, Sutliff RL et al. Chronic ethanol ingestion increases superoxide production and NADPH oxidase expression in the lung. Am J Respir Cell Mol Biol 2006; 34: 314-319
196. Bechara RI, Pelaez A, Palacio A, Joshi PC, Hart CM, Brown LA et al. Angiotensin II mediates glutathione depletion, transforming growth factor-beta1 expression, and epithelial barrier dysfunction in the alcoholic rat lung. Am J Physiol Lung Cell Mol Physiol 2005; 289: L363-L370
197. de Roux A, Cavalcanti M, Marcos MA, Garcia E, Ewig S, Mensa J et al. Impact of alcohol abuse in the etiology and severity of community-Acquired pneumonia. Chest 2006; 129: 1219-1225
198. Happel KI, Nelson S. Alcohol, immunosuppression, and the lung. Proc Am Thorac Soc 2005; 2: 428-432
199. Kono H, Rusyn I, Yin M, Gabele E, Yamashina S, Dikalova A et al. NADPH oxidase-derived free radicals are key oxidants in alcoholinduced liver disease. J Clin Invest 2000; 106: 867-872
200. Thurman RG. II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 1998; 275(4 Pt 1): G605-G611
201. Adachi Y, Bradford BU, Gao W, Bojes HK, Thurman RG. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 1994; 20: 453-460
202. Ma S, Yang D, Li D, Tang B, Yang Y. Oleic acid induces smooth muscle foam cell formation and enhances atherosclerotic lesion development via CD36. Lipids Health Dis 2011; 10: 53
203. Touyz RM, Montezano AC. Vascular Nox4: A multifarious NADPH oxidase. Circ Res 2012; 110: 1159-1161
204. Toma L, Stancu CS, Botez GM, Sima AV, SimionescuM. Irreversibly glycated LDL induce oxidative and inflammatory state in human endothelial cells; added effect of high glucose. Biochem Biophys Res Commun 2009; 390: 877-882
205. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695
206. Witztum JL, Steinberg D. The oxidative modification hypothesis of atherosclerosis: does it hold for humans?. Trends Cardiovasc Med 2001; 11: 93-102
207. Jonasson L, Holm J, Skalli O, Gabbiani G, Hansson GK. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest 1985; 76: 125-131
208. Azumi H, Inoue N, Takeshita S, Rikitake Y, Kawashima S, Hayashi Y et al. Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation 1999; 100: 1494-1498
209. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 1999; 85: 753-766
210. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M et al. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 2002; 91: 1160-1167
211. Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996; 93: 1354-1363
212. Yan ZQ, Hansson GK. Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev 2007; 219: 187-203
213. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983; 52: 223-261
214. Kalayoglu MV, Byrne GI. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun 1998; 66: 5067-5072
215. Kazemi MR, McDonald CM, Shigenaga JK, Grunfeld C, Feingold KR. Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by Toll-like receptor agonists. Arterioscler Thromb Vasc Biol 2005; 25:1220-1224
216. Krieger M, Acton S, Ashkenas J, Pearson A, Penman M, Resnick D. Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. J Biol Chem 1993; 268: 4569-4572
217. Hektoen L. The vascular changes of tuberculous meningitis, especially the tuberculous endarterities. J Exp Med 1896; 1: 112-163
218. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983-986
219. Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002; 91: 281-291
220. Tintut Y, Demer LL. Recent advances in multifactorial regulation of vascular calcification. Curr Opin lipidol 2001; 12: 555-560
221. Xu Q. Infections, heat shock proteins, and atherosclerosis. Curr Opin Cardiol 2003; 18: 245-252
222. Bulut Y, Faure E, Thomas L, Karahashi H, Michelsen KS, Equils O et al. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol 2002; 168: 1435-1440
223. Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, Hacker H et al. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 2001; 276: 31332-31339
224. Warnholtz A, Nickenig G, Schulz E, Macharzina R, Brasen JH, Skatchkov M et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-Angiotensin system. Circulation 1999; 99: 2027-2033
225. Violi F, Basili S, Nigro C, Pignatelli P. Role of NADPH oxidase in atherosclerosis. Future Cardiol 2009; 5: 83-92
226. Gregg D, Rauscher FM, Goldschmidt-Clermont PJ. Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch. Am J Physiol Cell Physiol 2003; 285: C723-C734
227. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97: 1916-1923
228. Wassmann S, Laufs U, Baumer AT, Muller K, Konkol C, SauerHet al. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol Pharmacol 2001; 59: 646-654
229. Vecchione C, Carnevale D, Di Pardo A, Gentile MT, Damato A, Cocozza G et al. Pressure-induced vascular oxidative stress is mediated through activation of integrin-linked kinase 1/betaPIX/Rac-1 pathway. Hypertension 2009; 54: 1028-1034
230. Djordjevic T, Hess J, Herkert O, Gorlach A, BelAiba RS. Rac regulates thrombin-induced tissue factor expression in pulmonary artery smooth muscle cells involving the nuclear factor-kappaB pathway. Antioxid Redox Signal 2004; 6: 713-720
231. Laufs U, Kilter H, Konkol C, Wassmann S, Bohm M, Nickenig G. Impact of HMG CoA reductase inhibition on small GTPases in the heart. Cardiovasc Res 2002; 53: 911-920
232. Mora-Pale M, Weiwer M, Yu J, Linhardt RJ, Dordick JS. Inhibition of human vascular NADPH oxidase by apocynin derived oligophenols. Bioorg Med Chem 2009; 17: 5146-5152
233. Touyz RM. Apocynin, NADPH oxidase, and vascular cells: A complex matter. Hypertension 2008; 51: 172-174
234. Stolk J, Hiltermann TJ, Dijkman JH, Verhoeven AJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol 1994; 11: 95-102
235. Ghosh M, Wang HD, McNeill JR. Role of oxidative stress and nitric oxide in regulation of spontaneous tone in aorta of DOCA-salt hypertensive rats. Br J Pharmacol 2004; 141: 562-573
236. Guzik TJ, Harrison DG. Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discov Today 2006; 11: 524-533
237. West NE, Qian H, Guzik TJ, Black E, Cai S, George SE et al. Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production. Circulation 2001; 104: 1526-1532
238. Ju KD, Shin EK, Cho EJ, Yoon HB, Kim HS, Kim H et al. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy. Am J Physiol Renal Physiol 2012; 302: F606-F613
239. Fink MP. Ethyl pyruvate: A novel anti-inflammatory agent. Crit Care Med 2003; 31(1 Suppl): S51-S56
240. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-1148
241. Yao R, Cheng X, Liao YH, Chen Y, Xie JJ, Yu X et al. Molecular mechanisms of felodipine suppressing atherosclerosis in highcholesterol-diet apolipoprotein E-knockout mice. J Cardiovasc Pharmacol 2008; 51: 188-195
242. Wang JP, Raung SL, Hsu MF, Chen CC. Inhibition by gomisin C (a lignan from Schizandra chinensis) of the respiratory burst of rat neutrophils. Br J Pharmacol 1994; 113: 945-953
243. Gupte SA. Glucose-6-phosphate dehydrogenase: A novel therapeutic target in cardiovascular diseases. Curr Opin Invest Drugs 2008; 9: 993-1000
244. Gupte SA, Kaminski PM, Floyd B, Agarwal R, Ali N, Ahmad M et al. Cytosolic NADPH may regulate differences in basal Nox oxidasederived superoxide generation in bovine coronary and pulmonary arteries. Am J Physiol Heart Circ Physiol 2005; 288: H13-H21
245. Yagi K. Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Methods Mol Biol 1998; 108: 107-110
246. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 2003; 285: R277-R297
247. Akard LP, English D, Gabig TG. Rapid deactivation of NADPH oxidase in neutrophils: continuous replacement by newly activated enzyme sustains the respiratory burst. Blood 1988; 72: 322-327
248. Jaquet V, Scapozza L, Clark RA, Krause KH, Lambeth JD. Smallmolecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid Redox Signal 2009; 11: 2535-2552
249. Liou KT, Shen YC, Chen CF, Tsao CM, Tsai SK. The antiinflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. Eur J Pharmacol 2003; 475: 19-27
250. Ding Y, Chen ZJ, Liu S, Che D, Vetter M, Chang CH. Inhibition of Nox-4 activity by plumbagin, a plant-derived bioactive naphthoquinone. J Pharm Pharmacol 2005; 57: 111-116
251. Nakashima T, Iwashita T, Fujita T, Sato E, Niwano Y, Kohno M et al. A prodigiosin analogue inactivates NADPH oxidase in macrophage cells by inhibiting assembly of p47phox and Rac. J Biochem 2008; 143: 107-115
252. ten Freyhaus H, Huntgeburth M, Wingler K, Schnitker J, Baumer AT, Vantler M et al. Novel Nox inhibitor VAS2870 attenuates PDGFdependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc Res 2006; 71: 331-341
253. Wind S, Beuerlein K, Armitage ME, Taye A, Kumar AH, Janowitz D et al. Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition. Hypertension 2010; 56: 490-497
254. Laleu B, Gaggini F, Orchard M, Fioraso-Cartier L, Cagnon L, Houngninou-Molango S et al. First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis. J Med Chem 2010; 53: 7715-7730
255. Drummond GR, Selemidis S, Griendling KK, Sobey CG. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 2011; 10: 453-471
256. Dahan I, Pick E. Strategies for identifying synthetic peptides to act as inhibitors of NADPH oxidases, or "all that you did and did not want to know about Nox inhibitory peptides". Cell Mol Life Sci 2012; 69: 2283-2305
257. Maupetit J, Derreumaux P, Tuffery P. A fast method for large-scale de novo peptide and miniprotein structure prediction. J Comput Chem 2010; 31: 726-738
258. DeLeo FR, Yu L, Burritt JB, Loetterle LR, Bond CW, Jesaitis AJ et al. Mapping sites of interaction of p47-phox and flavocytochrome b with random-sequence peptide phage display libraries. Proc Natl Acad Sci USA 1995; 92: 7110-7114
259. Kleinberg ME, Malech HL, Rotrosen D. The phagocyte 47-kilodalton cytosolic oxidase protein is an early reactant in activation of the respiratory burst. J Biol Chem 1990; 265: 15577-15583
260. DeLeo FR, Jutila MA, Quinn MT. Characterization of peptide diffusion into electropermeabilized neutrophils. J Immunol Methods 1996; 198: 35-49
261. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, Pagano PJ. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O2 2 and systolic blood pressure in mice. Circ Res 2001; 89: 408-414
262. Sumimoto H, Kage Y, Nunoi H, Sasaki H, Nose T, Fukumaki Y et al. Role of Src homology 3 domains in assembly and activation of the phagocyte NADPH oxidase. Proc Natl Acad Sci USA 1994; 91: 5345-5349
263. Finan P, Shimizu Y, Gout I, Hsuan J, Truong O, Butcher C et al. An SH3 domain and proline-rich sequence mediate an interaction between two components of the phagocyte NADPH oxidase complex. J Biol Chem 1994; 269: 13752-13755
264. McPhail LC. SH3-dependent assembly of the phagocyte NADPH oxidase. J Exp Med 1994; 180: 2011-2015
265. Selemidis S, Sobey CG, Wingler K, Schmidt HH, Drummond GR. NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther 2008; 120: 254-291
266. Ellis JA, Mayer SJ, Jones OT. The effect of the NADPH oxidase inhibitor diphenyleneiodonium on aerobic and anaerobic microbicidal activities of human neutrophils. Biochem J 1988; 251: 887-891
267. Bayraktutan U, Draper N, Lang D, Shah AM. Expression of functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells. Cardiovasc Res 1998; 38: 256-262
268. Pandey D, Chen F, Patel A, Wang CY, Dimitropoulou C, Patel VS et al. SUMO1 negatively regulates reactive oxygen species production from NADPH oxidases. Arterioscler Thromb Vasc Biol 2011; 31: 1634-1642
269. Tsunawaki S, Yoshida LS, Nishida S, Kobayashi T, Shimoyama T. Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase. Infect Immun 2004; 72: 3373-3382
270. Diatchuk V, Lotan O, Koshkin V, Wikstroem P, Pick E. Inhibition of NADPH oxidase activation by 4-(2-Aminoethyl)-benzenesulfonyl fluoride and related compounds. J Biol Chem 1997; 272: 13292-13301
271. Aharoni I, Pick E. Activation of the superoxide-generating NADPH oxidase of macrophages by sodium dodecyl sulfate in a soluble cellfree system: evidence for involvement of a G protein. J Leuk Biol 1990; 48: 107-115
272. Bohle A, Bader R, Grund KE, Mackensen S, Neunhoeffer J. Serum creatinine concentration and renal interstitial volume. Analysis of correlations in endocapillary (acute) glomerulonephritis and in moderately severe mesangioproliferative glomerulonephritis. Virchows Arch A Pathol Anat Histol 1977; 375: 87-96
273. Chakraborti S, Roy S, Mandal A, Chowdhury A, Chakraborti T. Role of PKC-zeta in NADPH oxidase-PKCalpha-Gialpha axis dependent inhibition of beta-Adrenergic response by U46619 in pulmonary artery smooth muscle cells. Arch Biochem Biophys 2013; 540: 133-144
274. Hoff P, Buttgereit F. NADPH oxidase 4 represents a potential target for the treatment of osteoporosis. Cell Mol Immunol 2014; 11: 317-319
275. Batra S, Cai S, Balamayooran G, Jeyaseelan S. Intrapulmonary administration of leukotriene B4 augments neutrophil accumulation and responses in the lung to Klebsiella infection in CXCL1 knockout mice. J Immunol 2012; 188: 3458-3468
276. Theivanthiran B, Batra S, Balamayooran G, Cai S, Kobayashi K, Flavell RA et al. NOD2 signaling contributes to host defense in the lungs against Escherichia coli infection. Infect Immun 2012; 80: 2558-2569
277. Akaike T, Noguchi Y, Ijiri S, Setoguchi K, Suga M, Zheng YM et al. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA 1996; 93: 2448-2453
278. Harper RW, Xu C, Eiserich JP, Chen Y, Kao CY, Thai P et al. Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium. FEBS Lett 2005; 579: 4911-4917
279. Edens WA, Sharling L, Cheng G, Shapira R, Kinkade JM, Lee T et al. Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J Cell Biol 2001; 154: 879-891
280. El Hassani RA, Benfares N, Caillou B, Talbot M, Sabourin JC, Belotte V et al. Dual oxidase2 is expressed all along the digestive tract. Am J Physiol Gastrointest Liver Physiol 2005; 288: G933-G942
281. WuY, Antony S, Juhasz A, Lu J, Ge Y, JiangG et al. Up-regulation and sustained activation of Stat1 are essential for interferon-gamma (IFN-gamma)-induced dual oxidase 2 (Duox2) and dual oxidase A2 (DuoxA2) expression in human pancreatic cancer cell lines. J Biol Chem 2011; 286: 12245-12256
282. Harper RW, Xu C, McManus M, Heidersbach A, Eiserich JP. Duox2 exhibits potent heme peroxidase activity in human respiratory tract epithelium. FEBS Lett 2006; 580: 5150-5154
283. Yoshizawa-Ogasawara A, Ogikubo S, Satoh M, Narumi S, Hasegawa T. Congenital hypothyroidism caused by a novel mutation of the dual oxidase 2 (DUOX2) gene. J Pediatr Endocrinol Metab 2013; 26: 45-52
284. Feng D, Yang C, Geurts AM, Kurth T, Liang M, Lazar J et al. Increased expression of NAD(P)H oxidase subunit p67(phox) in the renal medulla contributes to excess oxidative stress and salt-sensitive hypertension. Cell Metab 2012; 15: 201-208
285. Clark RA, Volpp BD, Leidal KG, Nauseef WM. Two cytosolic components of the human neutrophil respiratory burst oxidase translocate to the plasma membrane during cell activation. J Clin Invest 1990; 85: 714-721
286. Wientjes FB, Hsuan JJ, Totty NF, Segal AW. p40phox, a third cytosolic component of the activation complex of the NADPH oxidase to contain src homology 3 domains. Biochem J 1993; 296(Pt 3): 557-561
287. Abo A, Pick E, Hall A, Totty N, Teahan CG, Segal AW. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 1991; 353: 668-670
288. Gu Y, Filippi MD, Cancelas JA, Siefring JE, Williams EP, Jasti AC et al. Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science 2003; 302: 445-449
289. Wolpe SD, Davatelis G, Sherry B, Beutler B, Hesse DG, Nguyen HT et al. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 1988; 167: 570-581
290. Mandrekar P, Ambade A, Lim A, Szabo G, Catalano D. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology 2011; 54: 2185-2197